1.93
Überblick
Nachrichten
Preisverlauf
Optionskette
Financials
Warum fällt HRTX?
Forum
Prognose
Aktiensplit
Heron Therapeutics Inc Aktie (HRTX) Neueste Nachrichten
Lacklustre Performance Is Driving Heron Therapeutics, Inc.'s (NASDAQ:HRTX) 26% Price Drop - simplywall.st
Quinn Opportunity Partners LLC Acquires New Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Raymond James Financial Inc. Takes $208,000 Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Earns "Buy" Rating from Needham & Company LLC - MarketBeat
Wellington Management Group LLP Sells 8,105 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics’ (HRTX) Buy Rating Reiterated at Needham & Company LLC - Defense World
Raymond James Financial Inc. Takes Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Exploring High Growth Tech Stocks In The US Market April 2025 - Yahoo
Heron Therapeutics, Inc.'s (NASDAQ:HRTX) Path To Profitability - simplywall.st
Heron Therapeutics, Inc. (NASDAQ:HRTX) Position Increased by Charles Schwab Investment Management Inc. - Defense World
Loss-Making Heron Therapeutics, Inc. (NASDAQ:HRTX) Expected To Breakeven In The Medium-Term - Yahoo
Is Heron Therapeutics, Inc. (HRTX) The Hot Biotech Stock Under $5? - Insider Monkey
Reviewing Heron Therapeutics (NASDAQ:HRTX) and ULURU (OTCMKTS:ULUR) - Defense World
Richmond Brothers Inc. Raises Stake in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Tejara Capital Ltd Reduces Holdings in Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
10 Hot Biotech Stocks Under $5 - Insider Monkey
Monaco Asset Management SAM Sells 465,674 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Heron Therapeutics to Report Fourth Quarter and Full Year 2024 F - GuruFocus.com
Heron Therapeutics (HRTX) Projected to Post Quarterly Earnings on Tuesday - MarketBeat
StockNews.com Downgrades Heron Therapeutics (NASDAQ:HRTX) to Hold - MarketBeat
CM Management LLC Acquires 200,000 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Why Heron Therapeutics Inc Stock Might Make Sense If Bought Today - Stocks Register
Los Angeles Capital Management LLC Sells 153,181 Shares of Heron Therapeutics, Inc. (NASDAQ:HRTX) - MarketBeat
Principal Financial Group Inc. Raises Stock Position in Heron Therapeutics, Inc. (NASDAQ:HRTX) - Defense World
Heron Therapeutics (HRTX) to Release Quarterly Earnings on Tuesday - Defense World
Heron Therapeutics: Four Horse Race Of Approved Therapies (NASDAQ:HRTX) - Seeking Alpha
Heron Therapeutics (NASDAQ:HRTX) Downgraded by StockNews.com to Hold - Defense World
Heron Therapeutics (HRTX) to Release Earnings on Tuesday - MarketBeat
What is Northland Capmk's Estimate for HRTX Q1 Earnings? - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Stock Position Decreased by Los Angeles Capital Management LLC - The AM Reporter
Heron Therapeutics (NASDAQ:HRTX) Raised to "Buy" at StockNews.com - MarketBeat
Heron Therapeutics (NASDAQ:HRTX) Posts Earnings Results, Beats Expectations By $0.05 EPS - MarketBeat
Heron Therapeutics, Inc. (NASDAQ:HRTX) Shares Sold by D.A. Davidson & CO. - MarketBeat
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):